Aerie Pharmaceuticals Shares Jump Most Ever on Eye Drug Results

Aerie Pharmaceuticals Inc. shares jumped the most ever after the company’s experimental drug Rhopressa eased glaucoma-associated eye pressure in a final-stage trial.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.